echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > my country independently develops a variety of effective drugs for the new coronavirus

    my country independently develops a variety of effective drugs for the new coronavirus

    • Last Update: 2021-12-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    my country independently develops a variety of effective drugs for the new coronavirus
    my country independently develops a variety of effective drugs for new coronaviruses my country independently develops multiple effective drugs for new coronaviruses

    CCTV News: The number of mutations of the new crown virus has increased and the variant strains are prevalent in many countries.
    While the new crown vaccine has achieved effective prevention and control, the demand for effective drugs for the new crown virus has become more and more urgent
    .


    Where is the development of effective drugs for the new coronavirus in my country, and what are the candidate "seed drugs"? Next, let us take a look at the development of China's new crown drugs


    After the outbreak of the new crown pneumonia, China immediately deployed drug research and development tasks.
    On February 16, 2020, set up a scientific research team composed of the Ministry of Science and Technology, the Health Commission, the Ministry of Industry and Information Technology, the Development and Reform Commission, the Food and Drug Administration, the Bureau of Traditional Chinese Medicine and other departments.
    , Organize a national team of superior experts to focus on clinical treatment needs, and make every effort to promote the research and development of effective drugs and treatment technologies
    .


    According to the relevant person in charge, 53 scientific research emergency projects in the clinical treatment and drug sector have been approved, involving about 315 million yuan of state-appropriated funds


    The new coronavirus is a brand-new virus.
    There is still no conclusion about which drug can hit its "seven inches" and which "blocking" strategy can work
    .


    To this end, China has deployed three technical routes during the development of new coronavirus drugs


    The three technical routes have their own characteristics, and adopt different strategies to "block" the different physiological links of the new coronavirus infection of the human body
    .


    Take the inhibition of virus replication as an example.


    Up to now, China has formed a combination therapy of BRII-196 and BRII-198 neutralizing antibodies that block virus entry into cells, procrudide, azvudine that inhibits virus replication, and a monoclonal antibody BDB-001 that modulates the human immune system.
    A batch of key drugs such as injections
    .


    A variety of effective drugs for the new coronavirus independently developed by our R&D team have been used in clinical treatment


    Focus on the new crown pneumonia epidemic
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.